Personal information

Activities

Employment (2)

West Virginia University: Morgantown, WV, US

2006-01-01 to present | Professor (Chemical and Biomedical Engineering)
Employment
Source: Self-asserted source
David Klinke

Entelos Inc.: Foster City, California, US

1999 to 2005 | Biosystems Engineer (In Silico R&D)
Employment
Source: Self-asserted source
David Klinke

Education and qualifications (2)

Northwestern University: Evanston, IL, US

1992-09-01 to 1998-06-18 | Ph.D. (Chemical & Biological Engineering)
Education
Source: Self-asserted source
David Klinke

Virginia Tech: Blacksburg, Virginia, US

1987-08 to 1992-05 | B.S. Summa Cum Laude (Chemical Engineering)
Education
Source: Self-asserted source
David Klinke

Funding (5)

EAGER: Biomanufacturing: Selecting an appropriate conceptual model for the phenotypic evolution of cytotoxic T lymphocytes

2016-09-01 to 2019-08-31 | Grant
Directorate for Engineering (Arlington, US)
GRANT_NUMBER: 1644932
Source: Self-asserted source
David Klinke via DimensionsWizard

Integrative systems approach to identify local oncogenic modulation of the IL12 axis

Source: Self-asserted source
David Klinke via DimensionsWizard

CAREER: Interrogating Antagonistic Mechanisms of Signaling Cross-talk in Natural Killer Cells

2011-01-15 to 2016-07-31 | Grant
National Science Foundation - Directorate for Engineering (Arlington, US)
GRANT_NUMBER: 1053490
Source: Self-asserted source
David Klinke via DimensionsWizard

Dendritic Cell Heterogeneity in Toll-like receptor 4 Signaling: Concept Validatio

2009-09-16 to 2011-08-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1R56AI076221-01A1
Source: Self-asserted source
David Klinke via DimensionsWizard

Noncanonical signaling and Emergent Trastuzumab Resistance in Breast Cancer

Source: Self-asserted source
David Klinke via DimensionsWizard

Peer review (5 reviews for 3 publications/grants)

Review activity for Cellular and molecular bioengineering. (1)
Review activity for Journal for immunotherapy of cancer. (3)
Review activity for PLoS computational biology. (1)